- January 27, 2020 at 9:56 pm #9583MarshaParticipant
I am not sure if any of your drug reps have reached out to you in regards for the Ibrance change! Ibrance will now be switching to tablets and I have also learned they are blister packed.
I have asked my rep if the insurances will have any hiccups with the change (remembering when Imbruvica switched- many PBM’s still preferred the capsules) and rep said they would ask and get back to me. I am thinking that because Imbruvica Capsules were kept available, that, that was the reasoning for some insurances to state they preferred them over tablets. I have been told that Ibrance will only be available in tablet form.
Expected time frame to role out: APRIL 2020January 29, 2020 at 3:58 pm #9598VictoriaParticipant
Thanks for bringing this important update to the group! I would agree that there may be some delays with insurances around this change. I’ll see if we can find any further information.
MattMarch 2, 2020 at 10:14 pm #9769VictoriaParticipant
I see that Pfizer has updated their website to describe more of the details.
Curious if you’ve run into delays with insurances on the new NDC, etc?
Anything specific you are still seeking to learn/clarify?
MattMarch 16, 2020 at 1:17 pm #9815MarshaParticipant
They have not released the tablet form as of yet, so I have not been able to run any test claims for the Tablets. I will keep group informed if I come across a PBM that has preference!
- You must be logged in to reply to this topic.